Literature DB >> 19159915

[Patient selection for thrombolysis using perfusion and diffusion MRI. An overview].

G Thomalla1, P Ringleb, M Köhrmann, P D Schellinger.   

Abstract

Multiparametric MRI including diffusion and perfusion imaging provides information on the extent of irreversibly damaged ischemic and/or critically hypoperfused tissue. Magnetic resonance angiography provides additional information on vessel status. The concept of perfusion-diffusion mismatch allows the estimation of tissue at risk of infarction which might be salvaged by timely reperfusion. In large case series and nonrandomized cohort studies, perfusion-diffusion mismatch-based thrombolysis was performed not less than 3 h after symptom onset with excellent safety and signs of good efficacy. However no randomised controlled trial has confirmed this to date. Recent studies improved the understanding of the mismatch concept and identified reperfusion unequivocally as an important predictor of the clinical response to thrombolysis. At the moment MRI-based thrombolysis can be performed after 3 h based on individual benefit:risk assessment in experienced stroke centers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19159915     DOI: 10.1007/s00115-008-2592-1

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  38 in total

Review 1.  Thrombolysis in stroke beyond three hours: Targeting patients with diffusion and perfusion MRI.

Authors:  Steven Warach
Journal:  Ann Neurol       Date:  2002-01       Impact factor: 10.422

2.  Perfusion magnetic resonance imaging maps in hyperacute stroke: relative cerebral blood flow most accurately identifies tissue destined to infarct.

Authors:  M W Parsons; Q Yang; P A Barber; D G Darby; P M Desmond; R P Gerraty; B M Tress; S M Davis
Journal:  Stroke       Date:  2001-07       Impact factor: 7.914

Review 3.  Magnetic resonance imaging criteria for thrombolysis in acute cerebral infarct.

Authors:  N Hjort; K Butcher; S M Davis; C S Kidwell; W J Koroshetz; J Röther; P D Schellinger; S Warach; L Østergaard
Journal:  Stroke       Date:  2004-12-23       Impact factor: 7.914

4.  Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset.

Authors:  Anthony J Furlan; Dirk Eyding; Gregory W Albers; Yasir Al-Rawi; Kennedy R Lees; Howard A Rowley; Christian Sachara; Mariola Soehngen; Steven Warach; Werner Hacke
Journal:  Stroke       Date:  2006-03-30       Impact factor: 7.914

5.  MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study.

Authors:  Martin Köhrmann; Eric Jüttler; Jochen B Fiebach; Hagen B Huttner; Stefan Siebert; Christian Schwark; Peter A Ringleb; Peter D Schellinger; Werner Hacke
Journal:  Lancet Neurol       Date:  2006-08       Impact factor: 44.182

6.  The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase.

Authors:  Werner Hacke; Greg Albers; Yasir Al-Rawi; Julien Bogousslavsky; Antonio Davalos; Michael Eliasziw; Michael Fischer; Anthony Furlan; Markku Kaste; Kennedy R Lees; Mariola Soehngen; Steven Warach
Journal:  Stroke       Date:  2004-11-29       Impact factor: 7.914

7.  Which time-to-peak threshold best identifies penumbral flow? A comparison of perfusion-weighted magnetic resonance imaging and positron emission tomography in acute ischemic stroke.

Authors:  J Sobesky; O Zaro Weber; F-G Lehnhardt; V Hesselmann; A Thiel; C Dohmen; A Jacobs; M Neveling; W-D Heiss
Journal:  Stroke       Date:  2004-10-28       Impact factor: 7.914

8.  Expanding the window for thrombolytic therapy in acute stroke. The potential role of acute MRI for patient selection.

Authors:  G W Albers
Journal:  Stroke       Date:  1999-10       Impact factor: 7.914

9.  Evolution of regional changes in apparent diffusion coefficient during focal ischemia of rat brain: the relationship of quantitative diffusion NMR imaging to reduction in cerebral blood flow and metabolic disturbances.

Authors:  M Hoehn-Berlage; D G Norris; K Kohno; G Mies; D Leibfritz; K A Hossmann
Journal:  J Cereb Blood Flow Metab       Date:  1995-11       Impact factor: 6.200

10.  Sensitivity and interrater agreement of CT and diffusion-weighted MR imaging in hyperacute stroke.

Authors:  Dorothee Saur; Thomas Kucinski; Ulrich Grzyska; Bernd Eckert; Christian Eggers; Wolf Niesen; Volker Schoder; Hermann Zeumer; Cornelius Weiller; Joachim Röther
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

View more
  2 in total

1.  [Industry-funded therapy studies: what is in the pipeline?].

Authors:  P D Schellinger; M Köhrmann; J Röther
Journal:  Nervenarzt       Date:  2012-10       Impact factor: 1.214

2.  [Imaging-based indications for interventional treatment of stroke].

Authors:  J Fiehler; G Thomalla
Journal:  Nervenarzt       Date:  2015-10       Impact factor: 1.214

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.